月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
由 Bentham Science出版。ISSN: 1871 - 5273。中枢神经系统疾病-药物靶标旨在涵盖所有最新和杰出的发展，在药物化学，药理学，分子生物学，基因组学和生物化学的当代分子靶标涉及神经和中枢神经系统疾病，如疾病特异性蛋白，受体，酶，基因。每一期的杂志将包含一系列由该领域的领导者撰写的及时深入的评论，涵盖当前涉及神经和中枢神经系统疾病的药物靶点的一系列主题。随着用于神经和中枢神经系统药物发现的新型人类药物靶点的发现、鉴定、表征和验证的不断增长;这本杂志将是所有参与药物发现和开发的药物学家的必读书。以前的药物目标-中枢神经系统和神经系统疾病(1568-007X)。
http://benthamscience.com/journal/submit-abstract-online.php?journalID=cnsnddt#top
Published by Bentham Science Publishers. ISSN: 1871-5273.CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development. Formerly Current Drug Targets - CNS & Neurological Disorders (1568-007X).
